Dr.Tania Ray

Dr.ARUN SINGH

Abstract

Objective: To evaluate the outcome and usefulness (cost-benefit ratio) of a newly developed modified trabeculectomy in comparison to conventional shunt surgery for NVG patients. Method: 30 NVG patients were included, out of which 20(66.6%) undergone modified trabeculectomy and 10(33.3%) glaucoma shunt surgery during 2 years period. An 18-month follow up done at regular intervals. A multivariate prospective analysis of surgical outcomes was done in respect to the cost-benefit ratio, but it was mainly based on IOP control. Result: In the follow-up, no significant difference (P>0.05) was found in the surgical outcomes between both groups in immediate and late postoperative periods. Complete success rate 50% and qualified success rate 20% found in both groups. But the cost of shunt surgery is significantly higher (P<0.0001). Conclusion: Modified trabeculectomy may be considered as treatment option in developing countries like India in NVG patients with comparable outcome benefits.[advanced_iframe src="https://view.officeapps.live.com/op/embed.aspx?src=https://aiosproceedings.s3.ap-southeast-1.amazonaws.com/2021/E-Poster/FP535.pptx" width="100%" height="608"]